SCHEMBL21149245

SCHEMBL21149245

c1ccc2cc(-c3nc(-c4ccc(-c5cccc6sc7ccccc7c56)cc4)nc(-c4ccc(-c5cccc6sc7ccccc7c56)cc4)n3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 8/20 0.40
S1PR4 O95977 6/20 0.40
PIM1 P11309 1/20 0.36
CYP1A2 P05177 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALOX5 P09917 1/20 0.35
GSTP1 P09211 1/20 0.35
GPR3 P46089 1/20 0.34
APP P05067 1/20 0.34
BRDT Q58F21 1/20 0.34
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
LIMK1 P53667 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24266399 1.00 S1PR5 (0.40) S1PR5S1PR4PIM1CYP1A2SMN1; SMN2
SCHEMBL24266744 0.97 S1PR5 (0.41) S1PR5S1PR4PIM1CYP1A2SMN1; SMN2
SCHEMBL21148578 0.96 S1PR5 (0.40) S1PR5S1PR4PIM1SMN1; SMN2ALDH1A1
SCHEMBL21109249 0.96 S1PR5 (0.40) S1PR5S1PR4PIM1CYP1A2SMN1; SMN2
SCHEMBL21148221 0.95 S1PR5 (0.37) S1PR5S1PR4PIM1CYP1A2SMN1; SMN2
SCHEMBL27455376 0.95 S1PR5 (0.43) S1PR5S1PR4CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL21148579 0.94 S1PR5 (0.39) S1PR5S1PR4CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL21149198 0.94 S1PR5 (0.40) S1PR5S1PR4CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL24266824 0.93 S1PR5 (0.40) S1PR5S1PR4PIM1CYP1A2SMN1; SMN2
SCHEMBL21148232 0.93 S1PR5 (0.40) S1PR5S1PR4PIM1CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 S1PR5 3651/4885S1PR4 3107/4885PIM1 3381/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 S1PR5 3651/4885S1PR4 3107/4885PIM1 3381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.